Home

Katharine E. Spink

CIK 1457130 · EVP & COO · last filed 2017-06-28

Katharine E. Spink is an EVP & COO who has filed 23 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for AST.WS, was dated Jun 28, 2017. Across all open-market trades the lifetime net is −$337.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $480.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$480.3K

Companies

3

Total Filings

23

Lifetime Open-Market Net

-$337.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Asterias Biotherapeutics, Inc. (AST.WS) Delisted EVP & COO 10,949 — — -$148.2K 9 2017-06-28
Asterias Biotherapeutics, Inc. (AST) Delisted Chief Operating Officer 30,635 — — -$22.6K 6 2016-03-29
GERN SVP Alliance Mgmt & Operations 331,213 $1.45 $480.3K -$166.9K 8 2011-06-16

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-06-28 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Grant (A) — $0 EDGAR
2017-06-07 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Tax (F) −7,260 -$23.2K EDGAR
2017-04-03 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Grant (A) +18,209 $0 EDGAR
2017-01-11 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Mixed −7,659 -$22.0K EDGAR
2017-01-06 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Mixed — -$6.7K EDGAR
2016-11-28 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Mixed — -$7.7K EDGAR
2016-11-21 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Mixed — -$6.7K EDGAR
2016-10-11 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Mixed −7,659 -$19.6K EDGAR
2016-09-12 Asterias Biotherapeutics, Inc. (AST.WS) Delisted Sell (S) −19,336 -$68.0K EDGAR
2016-03-29 Asterias Biotherapeutics, Inc. (AST) Delisted Grant (A) +30,635 $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.